CLONAL EVOLUTION OF IMMUNOGLOBULIN HEAVY-CHAIN REARRANGEMENTS IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER ENGRAFTMENT IN SCID MICE

Citation
Ej. Steenbergen et al., CLONAL EVOLUTION OF IMMUNOGLOBULIN HEAVY-CHAIN REARRANGEMENTS IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER ENGRAFTMENT IN SCID MICE, Leukemia, 10(9), 1996, pp. 1471-1478
Citations number
35
Categorie Soggetti
Hematology,Oncology
Journal title
ISSN journal
08876924
Volume
10
Issue
9
Year of publication
1996
Pages
1471 - 1478
Database
ISI
SICI code
0887-6924(1996)10:9<1471:CEOIHR>2.0.ZU;2-F
Abstract
We grafted childhood B-precursor acute lymphoblastic leukemia (ALL) bo ne marrow (BM) cells into mice with severe combined immunodeficiency ( SCID), in order to study the clonal evolution of immunoglobulin heavy chain (IgH) rearrangements in the absence of selective pressure by che motherapy, BM cells from nine patients (six diagnosis samples and thre e relapse samples) were intravenously injected into SCID mice (three m ice for each patient). All mice injected with cells from four patients developed a leukemia-like illness 12-40 weeks after injection. By PCR , new subclones that were the result of ongoing IgH rearrangement acco rding to the mechanism operative in the injected cell populations (V-H -replacement or V-H to D-J(H) joining) were detected in the engrafted cell populations for all four patients. Subclones were mouse-specific, suggesting that subclone formation is a continuous process. Southern analysis after engraftment was unaltered as compared to the injected c ells for one patient and revealed changes indicative of altered clonal composition for three patients. For two patients the observed changes possibly reflect the initial engraftment of a limited number of cells and occurred without changes in other parameters of the engrafted cel l population, such as time needed for the development of leukemia, mac roscopic organ involvement, immunophenotype and S-phase fraction. In o ne patient, we demonstrated the selective outgrowth of only a single c ell type present at diagnosis, as characterized by IgH rearrangements. Our data show that evolution of clonal IgH rearrangements in B-precur sor ALL may occur without the selective pressure of chemotherapy. Addi tionally, in some patients subclones present at diagnosis, as defined by IgH rearrangements, also possess different biological properties.